epidemiology of malaria, clinical features, treatment and its control-ppt
DESCRIPTION
Malaria is a mosquito-borne infectious disease of humans caused by eukaryotic protists of the genus Plasmodium. It is widespread in tropical and subtropical regions, including much of Sub-Saharan Africa, Asia and the Americas. The disease results from the multiplication of malaria parasites within red blood cells, causing symptoms that typically include fever and headache, in severe cases progressing to coma, and death.TRANSCRIPT
Epidemiology of Malaria, clinical features, treatment
and its control
Dr.J.Nuchin. M.D.,M.B.A.,D.C.A.
Epidemiologist 16-03-2011
By the end of session, you would be expected to be able to describe:
Problem statement Life cycle of parasiteType of vectorClinical features8 important CFs of severe complicated malariaTreatment Diagnosis Control measures
Sir Ronald Ross (1857-1932)
• 1897: role of the mosquito.
• Nobel prize: 1902
Introduction… A protozoan disease caused by a parasite plasmodium A major parasitic cause of death in man One of the oldest recorded diseases Egyptian mummies with enlarged spleens (1000 BC). Hippocrates (460-370 B.C.)-Clear discussion of quartan and
tertian fevers made by in his Book of Epidemics, Noted relationship between enlarged spleens and marshes.
Region between Tigris and Euphrates was malarious (2000 BC).
Malaria was well known to the Ancient Greeks and Romans. The Romans thought the disease was caused by bad air (mal-
aria) from swamps, which they drained to prevent the disease. A tropical disease-considered as ‘king of tropical diseases’
Problem statement-World Has been a scourge of
mankind for the centuries Total death toll due to
malaria is more than that due to any other diseases or even wars
Endemic in 109 (in 2006) countries covering about 45% of global population
Burden – 300-500 million cases and 2-3 million deaths
African countries contribute 90% of the total burden
• Kills a child every 15 to 20 seconds or 8000 children per day
• Nine of 10 deaths globally are among sub-Saharan children under age 5.
• Responsible for 25% total child mortality in Africa
• 90 percent of global incidence of malaria occurs in 13 countries of Africa.
• Out of this more than 50% of cases are from Nigeria, Congo, Ethiopia, Tanzania and Kenya.
• In pregnant women, it causes abortion, still births, LBWs and neonatal deaths globally.
Indian scenario Has always been a home ground for malaria Before 1947 (preDDT era)- malaria was a major cause of
death In 1908, an outbreak in UP and Punjab killed more than
3 lakh people in just a span of 2 months In 1947, India had about 75 million cases and >50% of
total deaths were due to Malaria alone • All the aspects of life were affected directly or indirectly• Industrial and agricultural production was very low• At present, 2-2.5 million cases are being reported with
1000 deaths every year
1947
1961
1965
1976
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
2002
2003
2004
2005
0
10
20
30
40
50
60
70
80
75
6.47
1.81
No. of malaria cases( In Millions) in India since 1947 to 2005
In 1950s, India used to report about 75 million every year with around 7.5 million deaths
1961
1965
1976
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
2002
2003
2004
2005
0
1
2
3
4
5
6
7
Pv and Pf cases in millions since 1947 to 2005 in India
Major malaria ecotypes found in India
• Rural malaria-• Urban malaria-• Forest malaria• Irrigation malaria• Project malaria• Migration malaria• Border malaria
Factors responsible for the increase in VBDs
Poverty and rapid population growth IrrigationUrbanization and improper sanitation IndustrializationMigration and rapid population movementNatural disastersResistanceGlobal warmingPolitical instability Inadequate health infrastructure
1.1 billion people live on less than $1 a day.
2.7 billion people live on less than $2 a day.
IRRIGATION IN INDIA
22.626.25 29.12 30.57
37.141.21
52.0256.81
91.02
78.12
0
20
40
60
80
100
Pre 1st 1951-56
IInd1956-61
IIIrd1961-66
Annual1966-69
IVth 1969-74
Vth 1974-78
Annual1978-80
VIth1985-90
VIIth1990-95
Mill
ion
Hec
tare
s
Karnataka
A major CMD in the state. 7 districts namely DK,G,R,K,T,Bijapur and Bagalkot
together contributed >65% of the total burden in the state in 2010
The P.f cases are being decreased in Karnataka and not so in other parts of the country.
Double resistance has been recorded
MALARIA CASES IN Karnataka since 2006 to 2010
2006 2007 2008 2009 2010
62842
4935547344
36859
44108
Karnataka in 2006- 62864 cases
Dakshina kannada
21%
Kolar13%
Raichur12%Gulbarga
8%
Tumkur7%
Belgaum7%
Others32%
85% of the cases in the state were due to these 11 districts with 2 deaths in the year 2008
Kolar, 11%
Tumkur, 2%
Chitradurga, 4%
Bijapura, 6%
Bagalkot, 4%
U. Kannada, 1%
Gulbarga, 16%
Bellary, 4%
Raichur, 14%
Koppal, 9%
D.Kannada, 15%
% OF MALARIA CASES IN THE STATE-2008
85% of the case s in the s tate wer e
due to these 11 d istricts w ith 2 deaths
Contribution of malaria cases in the year 2009 in 10 districts of Karnataka- Total no of cases-36859.
Gulbarga
D.Kannada
Raichur
Koppal
Tumkur
Bijapura
Bagalkot
Chikkaballapura
Bellary
Udupi
28%18%
13%
8%
7%
6%
5%
5%
4%
4%
85% of the total cases in the year contributed by these 10 districts
No. of cases in 2010-Karnataka->85% of cases were due to these10 districts
Chitradurga
Udupi
Tumkur
Bijapura
Raichur
Bagalkot
Bellary
Koppal
D.Kannada
Gulbarga
1062
1483
1953
2047
3166
3702
3942
4105
6280
7100
2010
2006
2007
2008
2009
2010
24.5%
37%
23.2%
17.8%
18.2% PFR in Karnataka From 2006 to 2010
• Malaria status in Belgaum
Geographically the district has been divided into 3 parts
1) Hilly region- Khanapur 2) (South) Semi Malnad
– Savdatti, Hukkeri, Bailhongal and Belgaum
3) (North) Tropical Region- Athani, Raibagh, Gokak, Ramdurga and Chikkodi Taluks
Belgaum district• Taluks-10• GHs-9• CHCs-16• PHCs-140• SCs-660• M.O.s-165, HWs-745,LTs-121• Villages-1160• Rural population-3201814 (2001 census)• Urban population-1012691• Total population-4214505• Density-314 per sq mtr
• The average rain fall in the district is 808mm every year.
• Krishna, Malaprabha and Ghata prabha being the major rivers in the districts, it also has five small rivers namely Markhandeya, Hiranyakeshi, Mahadaayi, Vedaganga and Dudhaganga. Navilu Tirtha dam is built for Malaprabha river in Savadatti taluka and Hidkal dam for Ghataprabha river in Hukkeri taluka. These two huge dams provide irrigation facilities through canals for the 8 taluks of the district
• With many historical places to its credit and plenty of Jatraas, the district attracts travelers from the near by districts and neighboring states all through the year
Talukwise Malaria incidence-2008
Gokak59%
Savdatti18%
Ramdurg13%
Bailhonngal4% Belgaum
4%
Talukwise malaria incidence-2007
Gokak68%
Ramdurg13%
Soundatti10%
Bailhongal5%
Gokak23%
Bhailhongal10%
Belgaum11%
Khanapur5%
Ramadurga32%
Soudatti18%
Talukawise incidence of malaria cases-2009 Total cases-456
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
1251
2066
1576
879
633
1490
574
400
692
601
2102
63344343
2689
989
352869
1674
2859
4149
3908
2226
456
537
Malaria burden in Belgaum Dist. Since 1987 to 2010
2004
2005
2006
2007
2008
2009
2010
45.20%
39.50%
30.10%
28.00%
21.00%
19.00%
14.89%
PFR in Belgaum districtFrom 2004 to 2010
160
93 80
246
678
589551
386363
237
392 374
1
Mal
aria
cas
es
Jan to Dec
Malaria cases-2006 month wise-Total Cases-4149
Note the 2nd peak of disease
210154
181
299
421
560
429
305279
250
401 419
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
Monthwise no. of Malaria cases -2007Note the 2nd peak of disease
643408 373
776
14981849
1483
1072 960 836
1358 1334
0
500
1000
1500
2000
January to December
Monthwise no. of cases-2004 to 2007Note the 2nd peak of disease
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
208183 175
242
332355
208
127139
124
7657
Monthwise Malaria cases-2008
208183 175
242
332355
208
127 139 12476 57
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
Monthwise Malaria Cases-2008
210154 181
299
421
560
429
305 279 250
401 419
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
Monthwise Malaria Cases-2007
Jan Feb Mar Apr May Jun July Aug Sept Oct Nov Dec
29 2415
23 26
101
132
58 57
27 23 22
Month wise Malaria incidence in the district in the year 2010-Total no. of cases- 537
Jan Feb Mar Apr May Jun July Aug Sept Oct Nov Dec
4035 37
3329
3945
42
3036
41
49
Month wise incidence of Malaria in the year 2009- Total no. of cases-456
What’s the Good News?
• Every one of these deaths is preventable!!!
• Just a 3 day course of treatment can cure the disease
• No stigma associated with malaria• No “Save the Mosquito” groups
Endemicity and immunity to malaria
Endemicity Malaria is said to be endemic when there is a constant incidence
of cases over a period of many successive years. Endemic malaria may be present in various degrees. There are four grades A. Hypoendemicity – There is a little transmission and the disease
has little effect on the population. B. Mesoendemicity - varying intensity of transmission; typically
found in the small, rural communities of the sub-tropics. C. Hyperendemicity - intense but seasonal transmission; immunity
is insufficient to prevent the effects of malaria on all age groups.
contnd…
D. Holoendemicity - intense transmission occurs throughout the year. - As people are continuously exposed to malaria parasites, they gradually develop immunity to the disease.
- In these areas, severe malaria is mainly a disease of children from the first few months of life to age 5 years.
- Pregnant women are also highly susceptible Although seasonal variations in transmission may occur in holoendemic
areas, malaria transmission occurs all year round. Therefore, people acquire natural immunity and epidemics are unlikely.
Contnd…
Depending on the intensity of transmission, malaria can be stable or unstable, reflecting different epidemic scenarios.
Stable malaria: Sustained incidence over several years. Seasonal fluctuations in transmission may occur but epidemics are unlikely.
Unstable malaria: Marked variations in the incidence of malaria over
time. Population does not develop immunity and people of all ages are susceptible to severe disease when transmission increases.
Agent –Parasite-Plasmodium• Unicellular • 140 types are there of which only 4 can infect
man(P.vivax, falciparum, ovale and malariae)• Malaria also affects other animals like primates,
rodents, birds, bats and even cold blooded animals like lizards
• Some parasites infecting primates can also infect man- eg,-P.knowelesi, P.brasilianum and P.cyanomalgi
• Monkey malaria
Figure 11.30
Plasmodium Sporozoite
Different speciesP.vivax- all over world-less common in Africa
60-70% BTM MildAnaemia, splenic rupture rarely
P.falciparum-tropics and sub-tropics
25-35% MTM High degree parasitaemia, all deaths
P.malariae <1% BQM NS, found in Karnataka
P.ovale-very rare
NF BTM OM, in Africa
Mode of transmission
1. By bite of female anopheles mosquitoes2. By blood- Blood transfusion and contaminated
syringes and needles3. Mother to foetus.
Congenital malaria• Occurs in 5% of the babies borne to mothers who were
MP positive during pregnancy• Transplacental infection
– Can occur in all 4 species– Commonly seen P.v. and P.f. in endemic areas– P.m. infections in nonendemic areas due to long persistence of
species• Neonate can be diagnosed with parasitemia within 7 days
of birth • Fever, irritability, feeding problems, anemia,
hepatosplenomegaly, and jaundice
Life cycle of plasmodia• The parasite 2 cycles of development- the Human
cycle (asexual cycle) and Mosquito cycle (sexual cycle)
• Man is the intermediate host harbouring the larval stages
• Mosquito is the definitive host harbouring the adult stages
Asexual cycle or Human cycle• Begins with the injection of
sporozoites following the bite of infected mosquito
• Three phases are observed Phase 1-Hepatic phase (pre or
exo erythrocytic or tissue)- Sporozoites disappear from
the circulation within 45-60 mins
Many of them are destroyed by phagocytes and some reach the liver cells
After 1-2 weeks of development (depending upon the species) they become hepatic schizonts
Hepatic Cells with plasmodia
Hepatic schizoint- The actively dividing, multinucleated, parasite form in hepatocytes; produces no inflammatory response.
Pre-erythrocytic schizoints
Contnd… These hepatic schizoints eventually rupture,
releasing showers of merozoites which attack
RBCs.
Erythrocytic schizont: It is a multinucleated stage
in a RBC resulting from asexual multiplication of
trophozoite. Each schizont contains a species
determined number of meroziotes.
Merozoite: is a protozoan cell that arises from the
schizogony of a parent sporozoan and may enter
either the asexual or sexual phase of the life cycle.
Infective to other fresh RBCs.
The number of meroziotes released vary according to
the type of parasite
In case of P.f, as many as 40,000 and in others 2000-15,000 merozoites are released
Trophozoite: Metabolically active form of the malaria parasite living within the RBC; sometimes called the ring form.
In case of P.f, the intrahepatic schizoints rupture almost simultaneously and there is no persistent tissue- no secondary exo erythrocytic stage
On the contrary, the intrahepatic schizonts of other plasmodia do not burst all at the same time.
Some intrahepatic schizonts persist and remain dormant (hypnozoites) for considerable periods and later they cause relapses
Once the parasites enter RBCs, they do not reinvade the hepatic cells
Phase 2- Erythrocytic phase (erythrocytic schizogony)
Many of the merozoites are quickly destroyed and significant number of merozoites bind and enter the RBCs
Then they pass through the stages of trophozoites and schizonts
Each parasite spends two days in a red blood cell consuming the hemoglobin and reproducing.
Malaria parasites invading an RBC
Malaria parasites in the RBCs
Erythrocytic Schizogony• nuclear division =
begin schizont stage• 6-40 nuclei• budding merozoites =
segmenter• erythrocyte rupture
releases merozoites
gametocytes
erythrocytic schizogony• 48 hr in Pf, Pv, Po• 72 hr in Pm
Erythrocytic forms (signet)
Young ring form trophozoites
RBCs rupture releasing merozoites which infect the fresh RBCs
16 new parasites burst out to infect other red blood cells from each merozoite
The sporozoites first invade liver cells and asexually reproduce to produce huge numbers of merozoites which spread to red blood cells where more merozoites are produced through more asexual reproduction.
Duration of erythrocytic phase is constant for species to species
It is 48 hrs in case of P.v, P.f and P.o whereas 72 hrs in P.m
The cycle may be repeated many times and may end with complications or be slowed down by immunity of the host
Phase 3- Gametogony Some of the erythrocytic
forms do not divide but become male (smaller) and female (longer) gametocytes
These are infective to mosquitoes
Gametocytes always circulate in the subcutaneous capillaries
Characteristics of different speciesSpecies Duration of
tissue phase (days)
Incubation period (days)
Number of merozoites
/ cell
Red cells invaded
P. falciparum
5.5 – 7 8 - 11 40,000 cells of all ages
P. vivax 6-8 10 - 17 10,000 reticulocytes
P. ovale 9 10 – 17 15,000 reticulocytes
P. malariae 12-16 18 - 40 2,000 mature cells
Sexual or mosquito cycle
These infective gametocytes are ingested by the anopheles mosquitoes
Then develop and undergo stages of fertilisation- zygote, ookinate, oocyst and sporozoites
Sporozoites enter the salivary gland from the gut and are infective to man
Once in the mosquito, Plasmodium needs about 8-10 days to produce sporozoites that are ready to be injected into a human.
Plasmodia in Anopheles
Vector-Anopheles• Anopheles mosquitoes
65
Egg
6 – 8Days
Complete MetamorphosisTotal = 10 – 12
days
2 Days
2 Days
Life Cycle- 7days at 310c,20 days at 200c
Sl.No.
Common geographical area
Malaria vector Features
1 Urban area A.stephensi Breeds in used wells, overhead tanks2 Rural area A.culicifacies Zoophilic, wide distribution, high density required
for transmission, breeds in stagnant water, found in plains
3 Hilly area A.fluvitalis More anthrophilic, less density required for transmission, breeds in slow running water
4 Coastal area A.sundaicus Breeds in salt water,exophilic
5 Plantation area/Malnad area
A.minimus Breeds in slow running water
6 In water logging area
A.Philippensis Breeds in high level subsoil water, found in plains
Disease Potential is high in An. Minimus, An. Dirus, An. Fluviatilis, medium in An. stephensi An. sundaicus and low in An. culicifacies
An.culicifacies Breeding Sites
Host factors
Malaria affects all ages, but rare in newborn due to presence of foetal haemoglobin and maternal immunity
Common in males because of outdoor activities and clothing pattern (816 F -45% and 1014 M-55% out of 1830 in Belgaum till JAN 1998 to August 2008)
Duffy negative people are resistant to P.v. Most of the Africans are Duffy negative, this explains why P.v is not so common in Africa
Patients of SC trait ( Hb AS), G6PD and thalasseamia are less likely to be affected by malaria
High risk group Pregnant mothers- have an increased risk of severe malaria especially
in primigravidae, as the immunity to the malaria is impaired in pregnancy.Pregnant women attract twice the number of mosquitoes than non-pregnant women There is a greater susceptibility to P. falciparum than P. vivax during pregnancy
Children - Malaria affects cognitive development and learning abilities of children.
• Malaria is a risk factor of neuro-sensory and behavioral development in children
Immigrants from Europe- as they lack natural immunity
Immunity
• Occurs only after repeated exposure to the disease• Influenced by
– Genetics– Age– Health condition– Pregnancy status– Intensity of transmission in region– Length of exposure– Maintenance of exposure
Incubation period It is the length of time between the bite of infected
mosquito and appearance of first clinical feature (ie,fever). It is about 10-12 days in P.f and 10-14 days in other species
Prepatent period This is the length of time between the bite of infected
mosquito and appearance of parasites in peripheral blood
Clinical course
• Following a bite by an infected mosquito, many people do not develop any signs of infection. If infection does progress, the outcome is one of three depending on the host and parasite factors enumerated in the previous slides:
– Asymptomatic parasitaemia (“clinical immunity”)– Acute,(Simple) uncomplicated malaria– Severe malaria
Asymptomatic parasitaemia
• This is usually seen in older children and adults who have acquired natural immunity to clinical disease as a consequence of living in areas with high malaria endemicity.
• There are malaria parasites in the peripheral blood but no symptoms.
• These individuals may be important reservoirs for disease transmission.
• Some individuals may even develop anti-parasite immunity so that they do not develop parasitaemia following infection.
Simple, uncomplicated malaria
• This can occur at any age but it is more likely to be seen in individuals with some degree of immunity to malaria. The affected person, though ill, does not manifest life-threatening disease.
• Fever is the most constant symptom of malaria. It may occur in paroxysms when lysis of red cells releases merozoites resulting in fever, chills and rigors (uncontrollable shivering).
The periodicity of malaria fever• The first febrile attack corresponds to the development of parasites in the RBCs.• The fever may be continuous or remittent before it
becomes classically intermittent• Intermittent nature of the fever is due to cyclical release of
merozoites following rupture of infected RBCs• It is once in 48 hours in case of P.v, P.f (36 hrs- sub-tertian)
and P.o whereas 72 hours in P.m (erythrocytic schizogony is the time taken for
trophozoites to mature into merozoites before release when the cell ruptures).
Contnd…• A typical attack involves 3 distinct stages (in a
person from non-endemic area). Cold stageBegins with feeling of cold, shivering and headachePatient covers himself with blankets, BT reaches 39-
410CIt may continue for 15 mins to 1 hour
Parasites are demonstrable in the blood
Contnd…
Hot stage The fever raises so high so the patient feels
burning hot and takes off the clothesThe patient feels intense headache with nausea and
vomitingPulse is of bounding type, patient feels thirsty and it
may continue for 2-6hrs
Sweat stage Fever comes down with profuse sweatingHe goes usually into deep sleepLasts for 2-4 hoursFebrile herpes is very common Malaria- one clinical febrile episode of malaria
consumes 5,000 k Cal.
Note how the frequency of spikes of fever differ according to the Plasmodium species. In practice, spikes of fever in P. falciparum, occur irregularly - probably because of the presence of parasites at various stages of development.
Other features of simple, uncomplicated malaria include:
Malaria is a multisystem disease. Other common clinical features are: Vomiting
Diarrhoea – more commonly seen in young children and, when vomiting also occurs, may be misdiagnosed as viral gastroenteritis
Convulsions – commonly seen in young children. In an endemic area, cerebral malaria should be ruled out if any child fails to regain consciousness within an hour after an episode of febrile convulsion.
Pallor – resulting mainly from the lysis of RBCs. Malaria also reduces the synthesis of red blood cells in the bone marrow.
Jaundice – mainly due to haemolysis. (Serum bilirubin > 50 mol/1 or > 3 mg/dl.).
Contnd…
Anorexia Cough Headache Malaise Muscle aches Splenomegaly Tender hepatomegaly
These clinical features occur in “mild” malaria. However, the infection requires urgent diagnosis and management to prevent progression to severe disease.
Hepatosplenomegaly
Severe and complicated malaria
Although severe malaria is both preventable and treatable, it is frequently a fatal disease.
0.5 -2% of the total P.f malaria develop complications and of which 50% are fatal
The following are 8 important severe manifestations of malaria
1. Severe malaria anaemia2. Cerebral malaria3. Hypoglycaemia4. Metabolic acidosis5. Acute renal failure6. Pulmonary oedema7. Circulatory collapse, shock or “algid malaria”8. Blackwater fever
Note: It is common for an individual patient to have more than one severe manifestation of malaria!
Anaemia in malaria-Severe anaemia(haematocirt < 15% or haemoglobin < 5 g/dl).
It is severe in P.f infections as it attacks 20-35% of total RBCs whereas only 1% is affected in other plasmodia
CausesHaemolysis of infected RBCsHaemolysis of uninfected RBCsDyserythropoiesis (Bone marrow)Splenomegaly-erythrocyte sequestrationDepletion of folate stores
Immediate blood transfusion is required in majority of patients
Cerebral malaria• The most well-known severe manifestation of
malaria. Responsible for 80% of the total malaria deaths.
• Defined as:– unarousable coma persisting for more than
one hour – with asexual forms of P. falciparum in the
peripheral blood– other common causes of encephalopathy
excluded (WHO1999)Common in P.f infections where the erythrocytic schizogony takes place in the smaller capillaries of the internal organsResults in the blockage of capillaries by parasitized RBCs.
• reduced cerebral blood flow• cerebral hypoxia• release of cytokines
A 4 year old boy who was deeply comatose and had persistent deviation of the eyes
A young girl with cerebral malaria. Note the abnormal, decerebrate posturing
Occurs most commonly in young children although non-immune adults are also at risk.Cerebral malaria can rapidly progress to death, even with appropriate treatment. Case fatality is between 20-50%.
The illness may start with drowsiness and confusion and then progress to coma. The loss of consciousness is often preceded by repeated convulsions. Retinal haemorrhages may be seen on fundoscopy. In survivors, resolution of coma usually occurs within 1-2 days in children and within 2-4 days in adults but may be complicated by neurological sequelae in ~5% adults and >10% of children.
3. Hypoglycaemia
Blood sugar <2.5 mmol/L (i.e.,<40 mg/dl).
• Increases the risk of mortality and sequelae in children with cerebral malaria; may present with convulsions or a deterioration in level of consciousness.
• Results from a combination of factors:– reduced glycogen stores because of reduced food intake– increased metabolism due to fever and repeated
convulsions– glucose consumption by malaria parasites– cytokine or quinine-stimulated hyperinsulinaemia
4. Metabolic acidosis• Lactic acidosis is a major contributor and probably results from
tissue anoxia and anaerobic glycolysisPresents with deep, rapid respirations (as in diabetic ketoacidosis) Acidaemia (arterial pH < 7.25) or Acidosis (plasma bicarbonate < 15 mmol/1).
Lactic acidosis results from : Anaerobic glycolysis due to microvascular obstruction. Failure of hepatic and renal lactate clearance. Production of lactate by the parasite. Lactate levels rise after generalized convulsions.
5. Acute renal failure
• Occurs almost exclusively in adults and older children in areas of unstable malaria
• The kidneys are often slightly swollen. Tubular abnormalities consistent with acute tubular necrosis (ATN) are seen.
• Sequestration in glomerular capillaries,mesangial endothelial cell proliferation, and immunoglobulin deposits may be seen.
• Cortical necrosis never occurs.
• Affected patients are usually oliguric (urinary output <400 ml/day) or anuric (<50 ml/day)
• Renal failure may be associated with haemoglobinuria (Black water fever).
• Serum creatinine levels are elevated >3 mg/dl
Nephrosis
P. Malariae quarten nephrosis
Hyperparasitaemia>5% of RBCs are affected-P.falciparum
6. Acute pulmonary oedema
This is a grave and usually fatal manifestation of severe falciparum malaria and occurs mainly in adults.
Hyperparasitaemia (>5% of RBCs are parasitized), renal failure and pregnancy are recognised predisposing factors and the condition is commonly associated with hypoglycaemia and metabolic acidosis.
7. Circulatory collapse, shock, “algid malaria” Systolic BP < 50 mmHg in children and < 80 mmHg in adults defines hypotension/shock. Patient with severe malaria can develop sudden hypotension & become shocked. This is “Algid Malaria”. Features of circulatory collapse- cold/clammy skin, weak/ thready pulses, hypotension, peripheral cyanosis, peripheral vasoconstriction, and rapid feeble pulse with core/skin temperature difference of ≥ 10° C. “Algid malaria” is characterised by hypotension, vomiting, diarrhoea, rapid respiration and oliguria. This condition is associated with a poor prognosis.
8. Haemoglobinuria or “Blackwater Fever”Characterized by rapid, severe, massive intravascular haemolysis.It is associated with infection by P.f, most commonly seen in a non-immune person who has resided in the endemic country for the last 6 months to 1 year and inadequately treated by quinine.In these cases, quinine is a precipitating factor. It is triggered by exposure to cold, sun, fatigue, trauma, pregnancy, X-rays etc,. The condition presents with severe pallor, jaundice and passage of dark urine due to haemoglobinuria. It may be associated with acute renal failure.
A 3 year old boy with severe anaemia (Hb% 3.3 g/dl) and
dark urine (shown in the container)
Typical dark urine of Haemoglobinuria on Day 0 and cleared by Day3
in the clinical features of severe Summary of differences malaria in adults and children
Clinical Manifestation Children AdultsSimilar in adults and children • Prostration • Circulatory collapse
++++
++++
More common in children • Cerebral malaria• Severe anaemia• Multiple convulsions • Metabolic acidosis• Hypoglycaemia
+++ +++ ++++++++
++ +++
+ / -
More common in adults • Jaundice • Pulmonary oedema• Haemoglobinuria • Abnormal bleeding• Renal failure
+ + / - + / - + / -+ / -
++++++++
Frequency of occurrence
DiagnosisMalaria is a multisystem disease. It presents with a wide variety of non-specific
clinical features. None of the clinical features are pathognomonic.Many patients have fever, general aches and pains
and malaise and are initially misdiagnosed as having “flu”.
P. falciparum malaria can be rapidly progressive and fatal.
Diagnosis• A good history
– Residence or a recent visit (in the preceding 3 months) to a malaria endemic area
– History of fever – Recognise significance of non-specific clinical features such as
vomiting, diarrhoea, headache, malaise• Physical examination
– Identify signs consistent with malaria: fever, pallor, jaundice, Splenomegaly
– Exclude other possible causes of fever (e.g. signs of viral and bacterial infections)
The diagnosis of malaria should be considered in any unwell person who has been in a malarious area recently
Blood Film ExaminationThick and thin blood films (or “smears”) have remained the
gold standard for the diagnosis of malaria. The films are stained and examined by microscopy.
Thick blood film - Used for detecting malaria: a larger volume of blood is examined allowing detection of even low levels of parasitaemia. Also used for determining parasite density and monitoring the response to treatment.
Thin blood film – Gives more information about the parasite morphology and, therefore, is used to identify the particular infecting species of Plasmodium.
Appearance of P. falciparum in thin blood films. Ring forms or trophozoites; many red cells infected – some with more than one
parasite
Other methods of diagnosis of malaria
These are not routinely used in clinical practice. a) Antigen capture kits. Uses a dipstick and a finger prick blood
sample. Rapid test - results are available in 10-15 minutes. Expensive and sensitivity drops with decreasing parasitaemia.
b) PCR based techniques. Detects DNA or mRNA sequences specific to Plasmodium. Sensitivity and specificity high but test is expensive, takes several hours and requires technical expertise.
c) Fluorescent techniques- Relatively low specificity and sensitivity. Cannot identify the parasite species. Expensive and requires skilled personnel.
d) Serologic tests- Based on immunofluorescence detection of antibodies against Plasmodium species. Useful for epidemiologic and not diagnostic purposes.
Treatment
The treatment of malaria depends on a number of factors
1. Severity of the infection: whether simple, uncomplicated or severe, complicated malaria.
2. Parasite factors: species, drug sensitivity
3. Patient factors: age, pregnancy, prior chemoprophylaxis, known allergies, likelihood of drug compliance.
Drugs under NVBDCP- Malaria drug policy 20101. Chloroquine 2. Primaquine 3. ACT- Artesunte +Sulphadoxine /Sulfalene + Pyrimethamine
4. Quinine 5. Doxycycline6. Artesunate7. Artemether 8. Arteether
Treatment of uncomplicated malaria
Presumptive treatment: It is given to 1. All fever cases with H/O fever during past 15 days2. All fever cases irrespective of age and sex 3. No Primaquine to infants and pregnant women. 4. Each Chloroquine tab available as 150 mg and
Primaquine tab as 2.5 mg & 7.5 mg.Radical Treatment:5. Given after microscopic confirmation6. No Primaquine to infants and pregnant women. 7. Each Chloroquine tab available as 150 mg and
Primaquine tab as 2.5 mg & 7.5 mg.
PRESUMPTIVE YREATMENT – All fever cases are given tabs even before microscopic confirmation.(No more recommended under
MDP-2010-NVBDCP)No Primaquine to infants and pregnant women. Each Chloroquine tab
available as 150 mg and Primaquine tab as 2.5 mg
Age (Yr)
L R A H R AChloroquine(mg)
Chloroquine(mg) Primaquine(mg)
Base in mg.
Day 1
Day 2 Day 3 Day 1
0-1 75 75 75 37.5 -1-4 150 150 150 75 7.54-8 300 300 300 150 158-14 450 450 450 225 30>14 600 600 600 300 45
RADICAL TREATMENT- After microscopic confirmation No Primaquine to infants and pregnant women. Each Chloroquine tab available as 150 mg and Primaquine tab as 2.5 mg
Age (Yr) P.vivax P.falciparumChloroquine(mg)
Primaquine(mg)14 days
Chloroquine(mg)
Day1 Day2 Day3
Primaquine(mg)
0-1 75 - 75 75 37.5 -1-4 150 2.5 150 150 75 7.54-8 300 5 300 300 150 158-14 450 10 450 450 225 30>14 600 15 600 600 300 45
Site of Action
ChloroquineQuinine, SPArtemisinin
Quinine & Chloroquine in P.V. and Primaquine in P.F.
Primaquine
109
Drug Class
Drugs
Blood Schizontoc
idal
Chloroquine, Quinine, Quinidine, Mefloquine, Halofantrine, Sulfonamides, Tetracyclines,
Atovaquone, Artemisinin compounds Tissue
Schizontocidal
Primaquine, Proguanil, Pyrimethamine,
Gametocidal
Primaquine
Hypnozoitocidal
Primaquine
NA-not active, A-active,
Drug Sporozoites
Primary tissue phase
Asexualparasite
Gametocyte
Hypnozoite
Quinine NA NA A A-P.v NA
Chloroquine NA NA A A-P.v NA
Primaquine A A A in toxic dose
A A
SP Less A Little A on P.f
Incomplete NA NA
Mefloquine NA NA A NA NA
- 236 PHCs in 19 states are identified as Chloroquine resistant.
Avoid these combinations• Most antimalarial drugs have a long plasma half-life. Therefore,
adding similar drugs half way through the treatment will only add to the adverse effects and not to the therapeutic benefit. The following combinations should therefore be avoided, concurrently or within a short interval:
Both sulpha and primaquine can precipitate hemolytic crisis in patients with Glucose 6-phosphate dehydrogenase deficiency.
(1) Chloroquine + Quinine
(2) Chloroquine + Mefloquine
(3) Quinine + Mefloquine
(4) Quinine + Primaquine
(5) Quinine + Halofantrine
(6) Mefloquine + Primaquine
• National drug Policy on Malaria-2010-NVBDCP
National drug Policy on Malaria-2010-NVBDCP
1) Treatment of P.v infections- As discussed earlier2) Treatment of uncomplicated P.f. cases. a) Artemesinin based Combination Therapy-ACT Artesunate 4mg/kgBW daily for 3 days + sulfadoxine(25mg/kgBW)-Pyrimethamine
(1.25mg/kgBW) on 1st dayACT not to be given in 1st trimester of pregnancy(Each Sulfadoxine-Pyrimethamine(SP) contains 500mg
of Sulfadoxine and 25mg of Pyrimethamine)
Age-wise dosage for treatment of P.f cases
3) Treatment of uncomplicated P.f cases in pregnancy:1st trimester-Quinine salt 10mg/kgBW to be given 3 times daily for 7 daysII and III trimester: ACT as per dosage above
4)Treatment of mixed infections: All mixed infections should be treated with full course of ACT and Primaquine 0.25mg/kgBW daily for 14 days
5) Treatment of severe malaria cases: a) Artesunate: 2.4mg/kgBW IV or IM given on
admission, then at 12 hour and 24 hour and then once daily. OR
b) Artemether: 3.2mg/kgBW IM given on admission and then 1.6mg/kgBW per day. OR
c) Arteether: 150mg/kgBw IM daily for 3 daysin adults only (not to be given in children) OR
d) Quinine: 20mg/kgBW on admission (IV infusion or divided IM injection) followed by 10mg/kgBW 8th hrly. Infusion rate should not exceed 5mg/kgBW per hr.
Mass drug administration
• Recommended in API>5 per 1000 popn (WHO)• Not for under 5 children
Chemoprophylaxis- Use of anti-malarial drugs to prevent the
development of malaria is known as chemoprophylaxis.
- Unreliable with development of drug resistance- Started 1 week before arrival in the malarious area and
continued for atleast 4 weeks, preferably 6 weeks after leaving a HRA.
- Should be complemented by personal protection and other VCMs
Chemoprophylaxis - Recommended for 1.Travellers from non endemic areas2.As a short measure for soldiers, police and
labours serving in highly endemic areas3.All ANCs in HRAs- initiated in II semester
MALARIA TREATMENT COST OF
AN ADULT IN INDIADrugs Cost (Rs.) Chloroquine 3.50-10.00Chloroquine injection + fluids 200.00Sulfadoxine Pyrimethamine 7.00-30.00Mefloquine 240.00-300.00Artemether injections 390.00-1000.00Arteether injections 275.00Artesunate injections 1120.00Quinine tables + Tetracycline 270.00-210.00Quinine injections+IV fluid+Tetracycline 800-910 *Antipyretics @ Rs. 5.00-10.00 per treatmentI/V fluid may be required during Artemisinin treatment
HIV,Pregnant women and their fetus/newborn
• HIV does make malaria in pregnancy worse– More and higher density malaria, more illness, more
anemia, more low birth weight
• Malaria may make HIV worse– Higher HIV viral load – ? impact on Mother-to-Child Transmission (MTCT)
The Worlds Priorities? Annual ExpenditureGlobal Reduction in Malaria $ 1 billionBasic education for all $ 6 billion Cosmetics in the US $ 8 billionSafe water and sanitation $ 9 billion Ice cream in Europe $ 11 billionReproductive health for all women $ 12 billion Perfumes in Europe and the US $ 12 billion Basic health and nutrition $ 13 billion Pet food in Europe and the US $ 17 billionBusiness entertainment in Japan $ 35 billionCigarettes in Europe $ 50 billionAlcoholic drinks in Europe $ 105 billionNarcotic drugs in the world $ 400 billionMilitary spending in the world $ 780 billion
Source-Favaloro et al Circulation 1999
Prevention and Control of Malaria
Malaria vaccine
A burning issueSeveral vaccine candidates are now being tested in Africa, Asia and USA.Vaccines such as SPf66, RTs, S/AS02 developed by some countries failed to show required efficacy.Unlike other vaccines, a malaria vaccine even with only 50% efficacy would still be a very useful in controlling the disease.An effective vaccine is thought to be at least 10 years away (Park’s TB of PSM,20th edition)
Developing any vaccine is hard
Can take 10-20 years to develop a product and cost hundreds of millions of dollars.
Phase 3 Phase 2b
Phase 1a, 2aPre-clinicalLaboratory
Phase 1b
Integrated Vector Control Management: Appropriate combination of one or more methods
I V C or
Environmental management
IEC, community participation,Intersectoral
cooperation ,etc
Integrated vector control programmeOne of the main strategy is to reduce the man-
mosquito contact.There are many methods to curb the mosquito
nuisanceNo single method of control is likely to provide a
solution in all situations.Integrated approach is the present trend to obtain
maximum results with the minimum effort and to avoid the excessive use of any one method, implement in an effective manner simultaneously.
Mosquito control measuresVarious methods are classified as bellow
I. Anti-larval methodsII. Anti-adult measuresIII. Protection against mosquito
bites
I. Anti-larval methods i) Environmental control ii) Chemical control III) Biological control
i) Environmental control
• Source reduction - elimination of breeding sites by minor engineering methods- yield permanent results
a. Filling and levelling-the filling of depressions holding water and the levelling of ground
b. Drainage -Designed to remove and dispose off excess or unwanted water.
Contd…
If anopheles are a problem• filling and drainage If Mansonia are a problem• Removal of aquatic plants to which larvae
attach themselves
Contnd… If Culex are a problem• Abolish domestic and peri domestic sources such as
cesspools and open ditches• Adequate collection, removal and disposal of sewage
and waste water If Aedes are a problem• Remove the water holding containers such as
discarded tins, empty pots, broken bottles, coconut shells and similar other artificial collections of water
ii) Chemical control
The commonly used larvicides are Mineral oils Paris green and Synthetic insecticides
Dosage Larvicide
Dosage
Temephos (Abate) 50-100 gm/ha
Fenthion (Baytex) 25-100 gm/ha
Chloropyrifos 10-15gm/ha
Use and limitations
• Useful in control of urban mosquitoes & in the presence of other refractory situations .
• Important limitations : Larvae not killed develop into adult mosquitoes. Repeated every 7 to 10 days Thorough knowledge about the habitats and ecology
of the target species. Environmental contamination.
III. Biological control• Control of mosquito breeding by application of
biological control systems.• An innovative approach to the problem of
mosquitoes and the diseases they transmit.• Cost effective, non-polluting, resistance does not
develop.• Mosquitoes can be controlled by employing their
natural enemies viz., fishes, bugs, nematodes, bacteria and fungi.
A female western mosquitofish, Gambusia affinis
The guppy (Poecilia reticulata), also known as the millionfish, one of the most popular freshwater aquarium fish species in the world.
Guppy fish
Contnd…
For maximum efficacy: Remove predacious fishes . Clean water of all vegetation. Shore line should be of clear grass Fishes should not be released in extremely shallow water. Tie nylon or brass mesh at the submerged end of inlet or
outlet pipes.
Biocides
• Bacillus sphaericus & Bacillus thuringiensis• Used only under special situations.• Used to kill mosquito larvae.• Breeding places:selective water bodies in
domestic and peri-domestic areas.• Should not be used for larval control in
potable water.
II. Anti-adult measuresVarious methods are classified as bellow
i. Indoor Residual spraysii. Space sprays-Foggingiii. Environmental sanitationiv. Genetic control
Daily mortality of 15 to 35% may be sufficient to cause an interruption of transmission.
Imagiciding has gradually replaced larviciding.
Insecticidal dosage for IRSInsecticide
preparation
Per sq. mtr
Rounds/yr
Area to be covered
DDT 50% 1 Kg/10ltr 1 gm 2 500sq.mtr
Malathion 25%
2 Kg/10ltr 2gm 3 250sq.mtr
Cyfluthrin 10%
125 gm/10ltr
25mg 2 500sq.mtr
III. Protection against mosquito bitesVarious methods are classified as bellow
i. Mosquito nets (Insecticide Treated bed Nets-ITNs) are distributed in high risk area
ii. Screeningiii. Repellents
In and out door fogging
Portable fogging machines to combat mosquitoes
Different types of foggers
Defined (WHO) as “the development of an ability in strain of insects to tolerate doses of toxicants” This is considered as one of the main obstacles to using insecticides which would prove lethal to the majority of individual in normal population of the same species”for vector control.This is due to biochemical and genetic factors.
Insecticide Resistance by vectors
III. Prersonal protection
Offers protection during sleep.
Material should be white to allow easy detection of mosquitoes
Top as well as sides of the net should be of netting
Best pattern is rectangular net
Size of the hole should not exceed 0.0475 inch in any diameter
No. of holes in one square inch is usually 150.
1) Mosquito net
2)Screening Screening of building with
copper or bronze gauge having 16 meshes to the inch is recommended
Costly but gives excellent results
Hole should not exceed 0.0475 inch in any diameter
3) Repellents• For application over the skin• Diethyl tolbutamine (Deet) is used• Found to be effective against C.fatigans for 18-20
hours.
Biological Control for Adults
Biological Control for LarvaePredacaeous diving beetle
Water Striders
Backswimmers
Dragonfly & Damselfly larvae
Thank you Any ????